These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. RADIOACTIVE (I-125) HUMAN PLASMA CLOTS FOR ASSAY OF THROMBOLYTIC ACTIVITY. HUME M J Lab Clin Med; 1964 Apr; 63():699-702. PubMed ID: 14155458 [No Abstract] [Full Text] [Related]
3. [THE CURRENT STATUS OF FIBRINOLYTIC THERAPY]. KAPPERT A Med Klin; 1963 Nov; 58():1844-6. PubMed ID: 14100260 [No Abstract] [Full Text] [Related]
4. CLINICAL STUDIES ON AN ACTIVATOR FREE PORCINE PLASMIN (PLASMIN-NOVO). AMRIS CJ; LARSEN V; MOGENSEN B; STORM O Sangre (Barc); 1964; 61():12-8. PubMed ID: 14214872 [No Abstract] [Full Text] [Related]
5. [CHANGES IN THE BLOOD SERUM PICTURE PRODUCED BY INCREASED FIBRINOLYTIC ACTIVITY]. BIELAWIEC M Postepy Hig Med Dosw; 1963; 17():731-6. PubMed ID: 14125566 [No Abstract] [Full Text] [Related]
6. STUDIES ON THE THROMBOLYTIC ACTIVITY OF A PROTEASE FROM ASPERGILLUS ORYZAE. BERGKVIST R; SVAERD PO Acta Physiol Scand; 1964 Apr; 60():363-71. PubMed ID: 14157540 [No Abstract] [Full Text] [Related]
8. [RESEARCH ON RELATION BETWEEN COAGULABILITY AND FIBRINOLYTIC ACTIVITY IN VARIOUS TYPES OF COAGULATION DISORDERS]. PONARI O; CATTABIANI G; MASTANDREA R; DETTORI AG Hemostase; 1963; 3():219-30. PubMed ID: 14079438 [No Abstract] [Full Text] [Related]
9. [THROMBOLYSIS: DIRECT DETERMINATION OF FIBRINOLYTIC SUBSTANCES BY MEANS OF STATIC RETRACTROMETRY]. SCHULTE W Thromb Diath Haemorrh; 1964 Oct; 12():282-94. PubMed ID: 14224639 [No Abstract] [Full Text] [Related]
10. Fibrinolysis and coagulation. Effect of calcium and of coagulation on the lysis of fibrin clots. Helle I Scand J Haematol Suppl; 1968; 4():1-46. PubMed ID: 4181525 [No Abstract] [Full Text] [Related]
11. A QUANTITATIVE METHOD FOR MEASURING FIBRINOLYTIC ACTIVITY IN HUMANS. LANKFORD PG Am J Med Technol; 1965; 31():225-9. PubMed ID: 14295878 [No Abstract] [Full Text] [Related]
12. Effect of activation of the fibrinolytic mechanism on experimental platelet-rich thrombi in rabbits. Hirsh J; Buchanan M; Glynn MF; Mustard JF J Lab Clin Med; 1968 Aug; 72(2):245-55. PubMed ID: 5671200 [No Abstract] [Full Text] [Related]
13. OBSERVATIONS ON THE UPTAKE OF A RADIOACTIVE FIBRINOLYTIC ENZYME BY INTRAVASCULAR CLOTS. GOMEZ RL; WHEELER HB; BELKO JS; WARREN R Ann Surg; 1963 Nov; 158(5):905-11. PubMed ID: 14074083 [No Abstract] [Full Text] [Related]
14. [Which laboratory parameters are useful and necessary in fibrinolytic therapy?]. Theiss W Klin Wochenschr; 1988; 66 Suppl 12():55-8. PubMed ID: 3347008 [TBL] [Abstract][Full Text] [Related]
15. IMMUNOHISTOCHEMICAL STUDY OF THROMBOLYTIC MECHANISMS. BACK N; HIRAMOTO R; AMBRUS JL Blood; 1965 Jun; 25():1028-36. PubMed ID: 14294764 [No Abstract] [Full Text] [Related]
17. [EXPERIMENTAL ANIMAL DEMONSTRATION OF THE THROMBOLYTIC EFFECT OF HEPARIN OINTMENT WITH NEW INGREDIENTS]. KRAPFENBAUER H Wien Med Wochenschr; 1965 May; 115():417-8. PubMed ID: 14305202 [No Abstract] [Full Text] [Related]
18. [Hyperlipemia and hypofibrinolysis in arteriosclerotic disease]. Prino G; Mantovani M Boll Chim Farm; 1967 Feb; 106(2):67-84. PubMed ID: 4893083 [No Abstract] [Full Text] [Related]
19. [Laboratory monitoring of thrombolytic therapy in clinical practice and research]. Grünewald M; Seifried E Z Kardiol; 1993; 82 Suppl 2():129-35. PubMed ID: 8328190 [TBL] [Abstract][Full Text] [Related]
20. [Fibrinolysis and thrombolytic therapy under laboratory control]. Osten W Med Lab (Stuttg); 1966 May; 19(5):108-13 contd. PubMed ID: 5982109 [No Abstract] [Full Text] [Related] [Next] [New Search]